BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.

May 18–22, 2026 · Manchester, NH
MITM26 convenes leaders across regenerative medicine, advanced biomanufacturing, federal agencies, investment, workforce development, and policy to focus on one thing: execution at scale. If MITM25 showcased breakthrough science and emerging technologies, MITM26 is about impact—what’s working, where progress is being made, and how we scale it nationally. This year examines the real pathways required to move from concept to deployment, including manufacturing readiness, commercialization strategy, regulatory alignment, data and automation, and the workforce needed to support future clinical success.
What to Expect
Who should attend
Executives, operators, clinicians, regulators, investors, educators, and advocates building the U.S. bioeconomy.
Why it matters
MITM26 is where proven approaches move from pilots to production—advancing patient access, national readiness, and economic impact.
Details coming soon: speakers, agenda, registration, and sponsorship.